Long-Term Lamivudine Treatment of Children with Chronic Hepatitis B: Durability of Therapeutic Responses and Safety
Lamivudine has been demonstrated safe and efficacious in the short term in a large cohort of children with chronic hepatitis B (CHB), but optimal duration of treatment has not been elucidated and limited data on the safety of long-term lamivudine administration have been reported. In addition, the d...
Main Author: | |
---|---|
Other Authors: | , , |
Format: | article |
Language: | eng |
Published: |
2016
|
Subjects: | |
Online Access: | http://hdl.handle.net/10400.17/2505 |
Country: | Portugal |
Oai: | oai:repositorio.chlc.min-saude.pt:10400.17/2505 |